What is OutSense?
OutSense Diagnostics has developed an innovative technology that analyzes and diagnoses human waste from standard toilet bowls, providing critical health insights. Their IoT medical device autonomously scans waste and delivers real-time analysis to caregivers, enabling early detection of various medical conditions. The company's unique database on human excretions supports personalized healthcare and aids in medical research. OutSense targets healthcare providers, public health organizations, and pharmaceutical companies, aiming to transform human waste into lifesaving medical insights.
How much funding has OutSense raised?
OutSense has raised a total of $2.2M across 1 funding round:
Series A
$2.2M
Series A (2020): $2.2M with participation from Peregrine Ventures
Key Investors in OutSense
Peregrine Ventures
Peregrine Ventures is a venture capital firm dedicated to advancing medical innovation through global strategic investments, focusing on life science companies at various stages of development. They leverage deep industry knowledge to support portfolio companies in bringing groundbreaking healthcare technologies to market.
What's next for OutSense?
The substantial enterprise-level capital infusion positions OutSense for significant scaling and further development of its groundbreaking diagnostic technology. This strategic investment is expected to accelerate the company's market penetration within the healthcare provider, public health, and pharmaceutical sectors. Future endeavors will likely focus on expanding their proprietary database of human excretions, enhancing the analytical capabilities of their IoT devices, and forging deeper partnerships to integrate their lifesaving insights into mainstream personalized healthcare and medical research initiatives.
See full OutSense company page
